Skip to main content
ArticleOPEN ACCESS

Choosing ibrutinib wisely

Blood
DOI: 10.1182/blood-2017-11-813907
0Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Bartlett et al share their experience with the use of ibrutinib in patients with relapsed or refractory follicular lymphoma (FL).

Cite

CITATION STYLE

APA

Awan, F. T. (2018, January 11). Choosing ibrutinib wisely. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2017-11-813907

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free